Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2284834Generated: October 31, 2026

Hydrochloric Acid → HCID 91801199, compound

https://huagongshe.com/reaction/2284834

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantSodium HydroxideHCID 14798—
Reactant1,4-DioxaneHCID 31275—
ReactantBenzoic acid, 3-(chlorosulfonyl)-HCID 77641—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
ReactantHCID 71092623HCID 71092623—
ReactantHCID 118137315HCID 118137315—
Catalyst4-(Dimethylamino)pyridineHCID 14284—
SolventDimethylformamideHCID 6228—
SolventEthyl AcetateHCID 8857—
ProductHCID 91801199HCID 91801199—

Reaction Steps

To a solution of 4-((S)-2-(((S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carbonyl)oxy)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)ethyl)-3,5-dichloropyridine 1-oxide (I2, 270 mg, 0.44 mmol) dissolved in EtOAc (6 mL) was added a solution of HCl in dioxane (4 N, 7.2 mL, 28.8 mmol) at 0° C. The resulting mixture was stirred at 0° C. for 1 h before addition of HCl in dioxane (4 N, 2 mL, 8.0 mmol). The resulting slurry was stirred for 1 h and then the solvent was removed in vacuo. The residue was redissolved in DCM (50 mL) and washed with saturated aqueous NaHCO3 (20 mL). The organic phase was passed through a hydrophobic fit and the solvent was removed in vacuo to yield an oil that was used immediately without further purification. The residue was then taken up in acetone (4 mL) and THF (4 mL). 3-Chlorosulfonyl benzoic acid (845 mg, 3.86 mmol) and 2 M NaOH (3.86 mL, 7.72 mmol) were added at room temperature and the resulting mixture stirred for 16 h. After concentration in vacuo, the residue was diluted in DCM (50 mL) and the pH adjusted to 2 with an aqueous 1 N HCl saturated with brine. The organic phase was dried over MgSO4 and concentrated in vacuo. The resulting oil (195 mg) was used directly in the next step without further purification. To a solution of the carboxylic acid, (R)-quinuclidin-3-yl ((S)-(3-hydroxyphenyl)(phenyl)methyl)carbamate (197 mg, 0.56 mmol), 4-(dimethylamino)-pyridine (17 mg, 0.14 mmol) in DMF (2.5 mL) was added N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (107 mg, 0.56 mmol).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09145409B2
Source datasetuspto-grants-2015_09
ORD IDord-2842f029cfd74ae882dce0bb4a497e19
Source noteuspto-grants-2015_09